Cite
HARVARD Citation
Amoroso, L. et al. (2020). Genomic coamplification of CDK4/MDM2/FRS2 is associated with very poor prognosis and atypical clinical features in neuroblastoma patients. Genes, chromosomes & cancer. 59 (5), pp. 277-285. [Online].